, July 26, 2012
/PRNewswire/ -- Mycell Technologies LLC, a leading intellectual property and investment holding company, specializing in the development of proprietary liquid formulations of stable, highly concentrated omega-3s for use in food, beverage, medical and nutritional products, announced today the closing of an institutional non-controlling minority investment providing Mycell Technologies with an infusion of $10 million
. Terms of the transaction and investor names were not disclosed.
"We are now positioned for extraordinary growth at Mycell Technologies and Oceans Omega, our flagship ingredient subsidiary," said Benjamin D. Mamola, Chairman and Chief Executive Officer. "We are thankful to have a strategic institutional investor to share in this growth. In the coming weeks, we will be announcing additions to our management team and new partnerships to help continue our strong momentum."
About Mycell Technologies LLC (www.mycelltechnologies.com)
Mycell Technologies LLC is a leading intellectual property and investment holding company, creating proprietary liquid formulations of shelf-stable highly concentrated omega-3s.
About Oceans Omega LLC (www.oceansomega.com)
Oceans Omega LLC, a wholly-owned subsidiary of Mycell Technologies LLC, is one of the largest suppliers of stabilized omega-3 EPA/DHA ingredients to the food and beverage markets. Oceans Omega's liquid ingredient solutions represent exceptional advancements for incorporating and stabilizing omega-3 EPA/DHAs in food and beverages. Oceans Omega's unique stabilization and delivery technologies provide the purest, most stable omega-3 ingredients and lead the competition in every category. Oceans Omega's corporate offices are located in Paramus, New Jersey with manufacturing facilities in the Midwest.
Mycell Technologies LLC
SOURCE Mycell Technologies LLC